Change Over Time In The Profile Of Ankylosing Spondylitis Patients Treated With Infliximab In Canadian Routine Care

被引：0
|
作者：
Choquette, Denis [1 ]
Starr, Michael [2 ]
Khraishi, Majed M. [3 ]
Bensen, William G. [4 ,5 ]
Shaikh, Saeed A. [6 ]
Rodrigues, Jude F.
Sholter, Dalton E. [7 ]
Sheriff, Maqbool K. [8 ]
Vaillancourt, Julie [9 ]
Sampalis, John S. [10 ]
Lehman, Allen J. [11 ]
Otawa, Susan M. [11 ]
Nantel, Francois [11 ]
Shawi, May [11 ]
机构：
[1] Inst Rhumatol Montreal, Montreal, PQ, Canada
[2] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[3] Mem Univ Newfoundland, Nexus Clin Res, MD, St John, NF, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] McMaster Univ, St Catharines, ON, Canada
[7] Rheumatol Associates, Edmonton, AB, Canada
[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada
[9] JSS Med Res, Montreal, PQ, Canada
[10] JSS Med Res, St Laurent, PQ, Canada
[11] Janssen Canada Inc, Toronto, ON, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2458
引用
收藏
页码：S1051 / S1051
页数：1
相关论文
共 50 条
  • [21] CANaDian evaluation of low DosE infliximab in Ankylosing spondylitis (CANDLE)
    Inman, Robert
    Shojania, Kam
    Keystone, Ed
    Haraoui, Boulos
    Mitchell, Chad
    Maksymowych, Walter
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1213 - 1214
  • [22] Ankylosing spondylitis patients treated with infliximab had a sustained improvement in quality of life over two years.
    Braun, J.
    Kellner, H.
    Deodhar, A.
    Inman, R.
    Baker, D.
    Han, C.
    Han, J.
    Bala, M.
    van der Heijde, D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S476 - S477
  • [23] Infliximab in two patients with juvenile ankylosing spondylitis
    Schmeling, H
    Horneff, G
    RHEUMATOLOGY INTERNATIONAL, 2004, 24 (03) : 173 - 176
  • [24] Population pharmacokinetics of infliximab in patients with ankylosing spondylitis
    Xu, Zhenhua
    Seitz, Kathleen
    Fasanmade, Adedigbo
    Ford, Joyce
    Williamson, Paul
    Xu, Weichun
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06): : 681 - 695
  • [25] Infliximab in two patients with juvenile ankylosing spondylitis
    Heinrike Schmeling
    Gerd Horneff
    Rheumatology International, 2004, 24 : 173 - 176
  • [26] Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care
    Bessette, Louis
    Khraishi, Majed
    Pavlova, Viktoria
    Florica, Brandusa
    Remple, Valencia
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 818 - 818
  • [27] Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care
    Bessette, Louis
    Khraishi, Majed
    Pavlova, Viktoria
    Florica, Brandusa
    Remple, Valencia P.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] Real-Life Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 3 Years: The Canadian Experience
    Rahman, Proton
    Bensen, William
    Shaikh, Saeed
    Longo, Nadia
    Sampalis, John
    Kahlil, Hayssam
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1726 - 1726
  • [29] Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis
    Baert, Charlotte Anne
    Aydin, Selda
    Leroy, Philippe
    Durez, Patrick
    BMJ CASE REPORTS, 2021, 14 (01)
  • [30] Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab
    Starr, Michael
    Zummer, Michel
    Choquette, Denis
    Haraoui, Boulos
    Rahman, Proton
    Jones, Henry
    Sheriff, Maqbool
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Lehman, Allen
    Maslova, Karina
    Nantel, Francois
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1184 - 1184
12345